Association of Surgical Margin Status with Oncologic Outcome in Patients Treated with Breast-Conserving Surgery

We aimed to compare the prognosis of patients with close resection margins after breast-conserving surgery (BCS) with that of patients with negative margins and identified predictors of residual disease. A total of 542 patients with breast cancer who underwent BCS between 2003 and 2019 were selected...

Full description

Bibliographic Details
Main Authors: Sumin Chae, Sun Young Min
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Current Oncology
Subjects:
Online Access:https://www.mdpi.com/1718-7729/29/12/726
_version_ 1797460736361889792
author Sumin Chae
Sun Young Min
author_facet Sumin Chae
Sun Young Min
author_sort Sumin Chae
collection DOAJ
description We aimed to compare the prognosis of patients with close resection margins after breast-conserving surgery (BCS) with that of patients with negative margins and identified predictors of residual disease. A total of 542 patients with breast cancer who underwent BCS between 2003 and 2019 were selected and divided into the close margin (114 patients) and negative margin (428 patients) groups. The median follow-up period was 72 (interquartile range, 42–113) months. Most patients received radiation therapy (RTx) and systemic therapy according to their stage and molecular subtype. The 10-year locoregional recurrence-free survival rates of the close and negative margin groups were 88.2% and 95.5%, respectively (<i>p</i> = 0.001). Multivariable analysis showed that adjuvant RTx and margin status after definitive surgery were significantly associated with locoregional recurrence. Of the 57 patients who underwent re-excision, 34 (59.6%) had residual disease. Multivariable analysis revealed that a histological type of positive or close margins and multifocality were independent predictive factors for residual disease. Although the current guidelines suggest that <i>no ink on tumor</i> is an adequate margin after BCS, a close resection margin may be associated with locoregional failure. The treatment strategy for close resection margins after BCS should be based on individual clinicopathological features.
first_indexed 2024-03-09T17:09:17Z
format Article
id doaj.art-65139194ea9b4fcaa505634852993348
institution Directory Open Access Journal
issn 1198-0052
1718-7729
language English
last_indexed 2024-03-09T17:09:17Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Current Oncology
spelling doaj.art-65139194ea9b4fcaa5056348529933482023-11-24T14:12:29ZengMDPI AGCurrent Oncology1198-00521718-77292022-11-0129129271928310.3390/curroncol29120726Association of Surgical Margin Status with Oncologic Outcome in Patients Treated with Breast-Conserving SurgerySumin Chae0Sun Young Min1Department of Medicine, Graduate School, Kyung Hee University, Seoul 02447, Republic of KoreaDepartment of Surgery, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul 02447, Republic of KoreaWe aimed to compare the prognosis of patients with close resection margins after breast-conserving surgery (BCS) with that of patients with negative margins and identified predictors of residual disease. A total of 542 patients with breast cancer who underwent BCS between 2003 and 2019 were selected and divided into the close margin (114 patients) and negative margin (428 patients) groups. The median follow-up period was 72 (interquartile range, 42–113) months. Most patients received radiation therapy (RTx) and systemic therapy according to their stage and molecular subtype. The 10-year locoregional recurrence-free survival rates of the close and negative margin groups were 88.2% and 95.5%, respectively (<i>p</i> = 0.001). Multivariable analysis showed that adjuvant RTx and margin status after definitive surgery were significantly associated with locoregional recurrence. Of the 57 patients who underwent re-excision, 34 (59.6%) had residual disease. Multivariable analysis revealed that a histological type of positive or close margins and multifocality were independent predictive factors for residual disease. Although the current guidelines suggest that <i>no ink on tumor</i> is an adequate margin after BCS, a close resection margin may be associated with locoregional failure. The treatment strategy for close resection margins after BCS should be based on individual clinicopathological features.https://www.mdpi.com/1718-7729/29/12/726breast-conserving surgeryclose resection marginresidual diseaselocoregional recurrence
spellingShingle Sumin Chae
Sun Young Min
Association of Surgical Margin Status with Oncologic Outcome in Patients Treated with Breast-Conserving Surgery
Current Oncology
breast-conserving surgery
close resection margin
residual disease
locoregional recurrence
title Association of Surgical Margin Status with Oncologic Outcome in Patients Treated with Breast-Conserving Surgery
title_full Association of Surgical Margin Status with Oncologic Outcome in Patients Treated with Breast-Conserving Surgery
title_fullStr Association of Surgical Margin Status with Oncologic Outcome in Patients Treated with Breast-Conserving Surgery
title_full_unstemmed Association of Surgical Margin Status with Oncologic Outcome in Patients Treated with Breast-Conserving Surgery
title_short Association of Surgical Margin Status with Oncologic Outcome in Patients Treated with Breast-Conserving Surgery
title_sort association of surgical margin status with oncologic outcome in patients treated with breast conserving surgery
topic breast-conserving surgery
close resection margin
residual disease
locoregional recurrence
url https://www.mdpi.com/1718-7729/29/12/726
work_keys_str_mv AT suminchae associationofsurgicalmarginstatuswithoncologicoutcomeinpatientstreatedwithbreastconservingsurgery
AT sunyoungmin associationofsurgicalmarginstatuswithoncologicoutcomeinpatientstreatedwithbreastconservingsurgery